Purpura, Thrombotic Thrombocytopenic
-
Subject Areas on Research
-
A case of severe thrombotic thrombocytopenic purpura with concomitant Legionella pneumonia: review of pathogenesis and treatment.
-
ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.
-
Adjuvant low-dose rituximab and plasma exchange for acquired TTP.
-
Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology, and management.
-
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
-
Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
-
Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura.
-
Clinical problem-solving. Taken out of context.
-
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration.
-
Cortical blindness due to reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura and preeclampsia.
-
Critical care aspects of lung transplantation.
-
Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura.
-
Hemolytic anemia and metastatic carcinoma: case report and literature review.
-
Hereditary thrombotic thrombocytopenic purpura: microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency occurring in consecutive generations.
-
How I treat catastrophic thrombotic syndromes.
-
How I treat thrombocytopenia in pregnancy.
-
Idiopathic thrombocytopenic purpura: mother and neonate.
-
Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura.
-
Novel therapeutic approaches for thrombotic thrombocytopenic purpura.
-
Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state.
-
Platelet activation in patients with thrombotic thrombocytopenic purpura.
-
Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?
-
Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome.
-
ST-segment elevation myocardial infarction treated with thrombolytic therapy in a patient with thrombotic thrombocytopenic purpura.
-
Seasonal association of thrombotic thrombocytopenic purpura.
-
Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome.
-
TTP following ITP in an HIV-positive boy.
-
The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.
-
The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
-
Thrombophilia and thrombosis in thrombotic thrombocytopenic purpura.
-
Thrombotic thrombocytopenic purpura during immune reconstitution.
-
Thrombotic thrombocytopenic purpura induced by trimethoprim-sulfamethoxazole in a Jehovah's Witness.
-
Thrombotic thrombocytopenic purpura occurring despite absence of the spleen: report of case.
-
Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection.
-
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.
-
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).
-
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).
-
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR).
-
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.
-
Update on multi-center clinical trials in the United States.